FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003746601> ?p ?o ?g. }

• W2003746601 endingPage "1002" @default.
• W2003746601 startingPage "999" @default.
• W2003746601 abstract "Several recent investigations have demonstrated that matrix metalloproteinase-2 (MMP-2) binds to the cell surface and undergoes zymogen activation via a plasma membrane-associated activity. The purpose of this study was to determine if association of MMP-2 with the plasma membrane also modulates the catalytic efficiency of the active enzyme. Using density gradient centrifugation, we isolated the plasma membrane fractions of two ovarian adenocarcinoma cell lines, DOV 13 and OVCA 432, previously described either to express MMP-2 or to express no gelatinolytic metalloproteinases, respectively. While DOV 13 cells contained plasma membrane-associated MMP-2 and OVCA 432 did not, both cell types were able to bind exogenous MMP-2. Furthermore, plasma membrane fractions from these cells significantly enhanced the rate of cleavage of [14C]gelatin I substrate by both MMP-2•tissue inhibitor of metalloproteinases-2 (TIMP-2) complex (2.5-8-fold) and TIMP-2-free MMP-2 (5.9-fold). This stimulatory activity was dose-dependent, soluble in Triton X-100, and abolished by trypsin treatment of the membranes, but was stable to heat treatment. Plasma membrane stimulation of MMP-2 resulted in a 3.8-4.6-fold increase in the catalytic efficiency of gelatinolysis. These data suggest that, in addition to promoting zymogen activation, cell surface binding of MMP-2 may regulate enzyme activity by increasing the rate of substrate cleavage. Via this mechanism, tumor cell types that do not express MMPs (such as OVCA 432) nevertheless may be able to utilize exogenous MMP-2 to mediate proteolysis associated with invasion and metastasis. Several recent investigations have demonstrated that matrix metalloproteinase-2 (MMP-2) binds to the cell surface and undergoes zymogen activation via a plasma membrane-associated activity. The purpose of this study was to determine if association of MMP-2 with the plasma membrane also modulates the catalytic efficiency of the active enzyme. Using density gradient centrifugation, we isolated the plasma membrane fractions of two ovarian adenocarcinoma cell lines, DOV 13 and OVCA 432, previously described either to express MMP-2 or to express no gelatinolytic metalloproteinases, respectively. While DOV 13 cells contained plasma membrane-associated MMP-2 and OVCA 432 did not, both cell types were able to bind exogenous MMP-2. Furthermore, plasma membrane fractions from these cells significantly enhanced the rate of cleavage of [14C]gelatin I substrate by both MMP-2•tissue inhibitor of metalloproteinases-2 (TIMP-2) complex (2.5-8-fold) and TIMP-2-free MMP-2 (5.9-fold). This stimulatory activity was dose-dependent, soluble in Triton X-100, and abolished by trypsin treatment of the membranes, but was stable to heat treatment. Plasma membrane stimulation of MMP-2 resulted in a 3.8-4.6-fold increase in the catalytic efficiency of gelatinolysis. These data suggest that, in addition to promoting zymogen activation, cell surface binding of MMP-2 may regulate enzyme activity by increasing the rate of substrate cleavage. Via this mechanism, tumor cell types that do not express MMPs (such as OVCA 432) nevertheless may be able to utilize exogenous MMP-2 to mediate proteolysis associated with invasion and metastasis." @default.
• W2003746601 created "2016-06-24" @default.
• W2003746601 creator A5009371501 @default.
• W2003746601 creator A5034090671 @default.
• W2003746601 creator A5090928660 @default.
• W2003746601 date "1995-01-01" @default.
• W2003746601 modified "2023-09-30" @default.
• W2003746601 title "A Plasma Membrane-associated Component of Ovarian Adenocarcinoma Cells Enhances the Catalytic Efficiency of Matrix Metalloproteinase-2" @default.
• W2003746601 cites W1501988955 @default.
• W2003746601 cites W1534999453 @default.
• W2003746601 cites W1618760884 @default.
• W2003746601 cites W1700189391 @default.
• W2003746601 cites W1970702779 @default.
• W2003746601 cites W1979390430 @default.
• W2003746601 cites W2002181111 @default.
• W2003746601 cites W2015551618 @default.
• W2003746601 cites W2015849738 @default.
• W2003746601 cites W2044754306 @default.
• W2003746601 cites W2049631846 @default.
• W2003746601 cites W2079831464 @default.
• W2003746601 cites W2088129685 @default.
• W2003746601 cites W2092449976 @default.
• W2003746601 cites W2093042595 @default.
• W2003746601 cites W2123142773 @default.
• W2003746601 cites W2125311110 @default.
• W2003746601 cites W2154671319 @default.
• W2003746601 cites W2204518242 @default.
• W2003746601 cites W23122061 @default.
• W2003746601 cites W2401824567 @default.
• W2003746601 doi "https://doi.org/10.1074/jbc.270.3.999" @default.
• W2003746601 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7836420" @default.
• W2003746601 hasPublicationYear "1995" @default.
• W2003746601 type Work @default.
• W2003746601 sameAs 2003746601 @default.
• W2003746601 citedByCount "37" @default.
• W2003746601 countsByYear W20037466012013 @default.
• W2003746601 crossrefType "journal-article" @default.
• W2003746601 hasAuthorship W2003746601A5009371501 @default.
• W2003746601 hasAuthorship W2003746601A5034090671 @default.
• W2003746601 hasAuthorship W2003746601A5090928660 @default.
• W2003746601 hasBestOaLocation W20037466011 @default.
• W2003746601 hasConcept C109523444 @default.
• W2003746601 hasConcept C1491633281 @default.
• W2003746601 hasConcept C181199279 @default.
• W2003746601 hasConcept C185592680 @default.
• W2003746601 hasConcept C2778106830 @default.
• W2003746601 hasConcept C2778775115 @default.
• W2003746601 hasConcept C2780340462 @default.
• W2003746601 hasConcept C41625074 @default.
• W2003746601 hasConcept C55493867 @default.
• W2003746601 hasConcept C55728118 @default.
• W2003746601 hasConcept C86803240 @default.
• W2003746601 hasConcept C95444343 @default.
• W2003746601 hasConceptScore W2003746601C109523444 @default.
• W2003746601 hasConceptScore W2003746601C1491633281 @default.
• W2003746601 hasConceptScore W2003746601C181199279 @default.
• W2003746601 hasConceptScore W2003746601C185592680 @default.
• W2003746601 hasConceptScore W2003746601C2778106830 @default.
• W2003746601 hasConceptScore W2003746601C2778775115 @default.
• W2003746601 hasConceptScore W2003746601C2780340462 @default.
• W2003746601 hasConceptScore W2003746601C41625074 @default.
• W2003746601 hasConceptScore W2003746601C55493867 @default.
• W2003746601 hasConceptScore W2003746601C55728118 @default.
• W2003746601 hasConceptScore W2003746601C86803240 @default.
• W2003746601 hasConceptScore W2003746601C95444343 @default.
• W2003746601 hasIssue "3" @default.
• W2003746601 hasLocation W20037466011 @default.
• W2003746601 hasOpenAccess W2003746601 @default.
• W2003746601 hasPrimaryLocation W20037466011 @default.
• W2003746601 hasRelatedWork W1437588494 @default.
• W2003746601 hasRelatedWork W1961048777 @default.
• W2003746601 hasRelatedWork W1984497270 @default.
• W2003746601 hasRelatedWork W1988804288 @default.
• W2003746601 hasRelatedWork W2025552622 @default.
• W2003746601 hasRelatedWork W2078595220 @default.
• W2003746601 hasRelatedWork W2172950699 @default.
• W2003746601 hasRelatedWork W2399964344 @default.
• W2003746601 hasRelatedWork W4249028109 @default.
• W2003746601 hasRelatedWork W586922465 @default.
• W2003746601 hasVolume "270" @default.
• W2003746601 isParatext "false" @default.
• W2003746601 isRetracted "false" @default.
• W2003746601 magId "2003746601" @default.
• W2003746601 workType "article" @default.